ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,520 | -24.3% | 15,500 | 0.0% | 0.01% | -33.3% |
| Q1 2023 | $37,665 | +48.8% | 15,500 | -12.5% | 0.01% | +33.3% |
| Q4 2022 | $25,320 | -48.3% | 17,706 | -18.7% | 0.01% | -50.0% |
| Q3 2022 | $49,000 | +8.9% | 21,777 | 0.0% | 0.02% | +20.0% |
| Q2 2022 | $45,000 | -40.0% | 21,777 | -15.5% | 0.02% | -31.8% |
| Q1 2022 | $75,000 | -15.7% | 25,777 | -7.2% | 0.02% | -8.3% |
| Q4 2021 | $89,000 | -10.1% | 27,777 | -0.2% | 0.02% | 0.0% |
| Q3 2021 | $99,000 | +20.7% | 27,827 | +7.7% | 0.02% | +26.3% |
| Q2 2021 | $82,000 | -20.4% | 25,827 | -13.4% | 0.02% | -24.0% |
| Q1 2021 | $103,000 | +37.3% | 29,827 | 0.0% | 0.02% | +25.0% |
| Q4 2020 | $75,000 | +19.0% | 29,827 | 0.0% | 0.02% | +5.3% |
| Q3 2020 | $63,000 | +5.0% | 29,827 | +11.2% | 0.02% | -5.0% |
| Q2 2020 | $60,000 | +9.1% | 26,827 | +22.9% | 0.02% | -4.8% |
| Q1 2020 | $55,000 | +10.0% | 21,827 | +15.9% | 0.02% | +16.7% |
| Q4 2019 | $50,000 | -26.5% | 18,827 | 0.0% | 0.02% | -18.2% |
| Q3 2019 | $68,000 | +7.9% | 18,827 | 0.0% | 0.02% | +10.0% |
| Q2 2019 | $63,000 | +23.5% | 18,827 | 0.0% | 0.02% | +42.9% |
| Q1 2019 | $51,000 | +15.9% | 18,827 | +19.0% | 0.01% | -17.6% |
| Q4 2018 | $44,000 | -17.0% | 15,827 | +23.4% | 0.02% | -5.6% |
| Q3 2018 | $53,000 | -13.1% | 12,827 | +8.5% | 0.02% | -25.0% |
| Q2 2018 | $61,000 | -14.1% | 11,827 | -9.0% | 0.02% | -14.3% |
| Q1 2018 | $71,000 | -41.8% | 12,992 | -13.3% | 0.03% | -44.0% |
| Q4 2017 | $122,000 | -16.4% | 14,992 | +7.1% | 0.05% | -13.8% |
| Q3 2017 | $146,000 | +2.1% | 13,992 | +7.7% | 0.06% | +3.6% |
| Q2 2017 | $143,000 | +31.2% | 12,992 | 0.0% | 0.06% | +24.4% |
| Q1 2017 | $109,000 | +21.1% | 12,992 | 0.0% | 0.04% | +21.6% |
| Q4 2016 | $90,000 | +36.4% | 12,992 | 0.0% | 0.04% | +27.6% |
| Q3 2016 | $66,000 | -16.5% | 12,992 | -1.6% | 0.03% | -14.7% |
| Q2 2016 | $79,000 | +31.7% | 13,203 | 0.0% | 0.03% | +21.4% |
| Q1 2016 | $60,000 | +9.1% | 13,203 | +8.2% | 0.03% | +7.7% |
| Q4 2015 | $55,000 | +52.8% | 12,203 | +8.9% | 0.03% | +44.4% |
| Q3 2015 | $36,000 | +16.1% | 11,203 | +9.8% | 0.02% | +50.0% |
| Q2 2015 | $31,000 | – | 10,203 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |